BETAGAN 0.25 % Ophthalmic Solution
RxNorm 1150834
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1150834 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: BETAGAN 0.25 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
BETAGAN 0.25 % Ophthalmic Solution
(Atom ID: 6401097)
SYPrescribable
Synonym (SY):
Betagan 0.25 % Ophthalmic Solution
(Atom ID: 3265521)
SYPrescribable
Synonym (SY):
Betagan 2.5 mg/ML Ophthalmic Solution
(Atom ID: 1152703)
SBDPrescribable
Semantic Branded Drug (SBD):
Levobunolol hydrochloride 2.5 mg/ML Ophthalmic Solution [Betagan]
(Atom ID: 12367769)
Patient Education
Levobunolol Ophthalmic
Ophthalmic levobunolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Levobunolol is in a class of medications called beta blockers. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.